Annual Net Income
-$154.96 M
-$39.64 M-34.37%
December 31, 2023
Summary
- As of February 8, 2025, INBX annual net profit is -$154.96 million, with the most recent change of -$39.64 million (-34.37%) on December 31, 2023.
- During the last 3 years, INBX annual net income has fallen by -$78.84 million (-103.57%).
- INBX annual net income is now -697.06% below its all-time high of -$19.44 million, reached on December 31, 2017.
Performance
INBX Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$43.86 M
-$1.90 B-102.36%
September 30, 2024
Summary
- As of February 8, 2025, INBX quarterly net profit is -$43.86 million, with the most recent change of -$1.90 billion (-102.36%) on September 30, 2024.
- Over the past year, INBX quarterly net income has dropped by -$1.90 billion (-102.36%).
- INBX quarterly net income is now -102.36% below its all-time high of $1.86 billion, reached on June 30, 2024.
Performance
INBX Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
$1.76 B
+$7.92 M+0.45%
September 30, 2024
Summary
- As of February 8, 2025, INBX TTM net profit is $1.76 billion, with the most recent change of +$7.92 million (+0.45%) on September 30, 2024.
- Over the past year, INBX TTM net income has increased by +$7.92 million (+0.45%).
- INBX TTM net income is now at all-time high.
Performance
INBX TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
INBX Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -34.4% | -102.4% | +0.5% |
| 3 y3 years | -103.6% | -10.7% | +1244.4% |
| 5 y5 years | -397.3% | -10.7% | +1244.4% |
INBX Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -89.5% | at low | -102.4% | +15.3% | at high | +1079.9% |
| 5 y | 5-year | -201.5% | at low | -102.4% | +15.3% | at high | +1079.9% |
| alltime | all time | -697.1% | at low | -102.4% | +15.3% | at high | +1079.9% |
Inhibrx Biosciences Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$43.86 M(-102.4%) | $1.76 B(+0.5%) |
| Jun 2024 | - | $1.86 B(-3870.9%) | $1.75 B(-1226.5%) |
| Mar 2024 | - | -$49.27 M(+583.7%) | -$155.32 M(+6.6%) |
| Dec 2023 | -$154.96 M(+34.4%) | -$7.21 M(-86.1%) | -$145.66 M(-18.8%) |
| Sep 2023 | - | -$51.79 M(+10.1%) | -$179.37 M(+10.1%) |
| Jun 2023 | - | -$47.05 M(+18.8%) | -$162.90 M(+6.1%) |
| Mar 2023 | - | -$39.61 M(-3.2%) | -$153.58 M(+5.8%) |
| Dec 2022 | -$115.33 M(+41.0%) | -$40.91 M(+15.8%) | -$145.23 M(+15.7%) |
| Sep 2022 | - | -$35.33 M(-6.4%) | -$125.50 M(+13.3%) |
| Jun 2022 | - | -$37.73 M(+20.7%) | -$110.75 M(+18.2%) |
| Mar 2022 | - | -$31.25 M(+47.5%) | -$93.73 M(+14.6%) |
| Dec 2021 | -$81.77 M | -$21.19 M(+3.0%) | -$81.77 M(+4.5%) |
| Sep 2021 | - | -$20.58 M(-0.6%) | -$78.23 M(+0.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | -$20.71 M(+7.4%) | -$78.14 M(+3.8%) |
| Mar 2021 | - | -$19.29 M(+9.3%) | -$75.32 M(-1.1%) |
| Dec 2020 | -$76.12 M(+48.1%) | -$17.65 M(-13.9%) | -$76.12 M(+1.8%) |
| Sep 2020 | - | -$20.50 M(+14.6%) | -$74.78 M(+0.4%) |
| Jun 2020 | - | -$17.89 M(-11.0%) | -$74.45 M(+10.1%) |
| Mar 2020 | - | -$20.09 M(+23.2%) | -$67.65 M(+31.6%) |
| Dec 2019 | -$51.40 M(+64.9%) | -$16.30 M(-19.1%) | -$51.40 M(+46.5%) |
| Sep 2019 | - | -$20.16 M(+81.9%) | -$35.09 M(+135.0%) |
| Jun 2019 | - | -$11.09 M(+188.1%) | -$14.93 M(+35.7%) |
| Mar 2019 | - | -$3.85 M(-46.2%) | -$11.00 M(-33.4%) |
| Dec 2018 | -$31.16 M(+60.3%) | - | - |
| Jun 2018 | - | -$7.16 M(-23.5%) | -$16.51 M(+76.5%) |
| Mar 2018 | - | -$9.36 M | -$9.36 M |
| Dec 2017 | -$19.44 M | - | - |
FAQ
- What is Inhibrx Biosciences annual net profit?
- What is the all time high annual net income for Inhibrx Biosciences?
- What is Inhibrx Biosciences annual net income year-on-year change?
- What is Inhibrx Biosciences quarterly net profit?
- What is the all time high quarterly net income for Inhibrx Biosciences?
- What is Inhibrx Biosciences quarterly net income year-on-year change?
- What is Inhibrx Biosciences TTM net profit?
- What is the all time high TTM net income for Inhibrx Biosciences?
- What is Inhibrx Biosciences TTM net income year-on-year change?
What is Inhibrx Biosciences annual net profit?
The current annual net income of INBX is -$154.96 M
What is the all time high annual net income for Inhibrx Biosciences?
Inhibrx Biosciences all-time high annual net profit is -$19.44 M
What is Inhibrx Biosciences annual net income year-on-year change?
Over the past year, INBX annual net profit has changed by -$39.64 M (-34.37%)
What is Inhibrx Biosciences quarterly net profit?
The current quarterly net income of INBX is -$43.86 M
What is the all time high quarterly net income for Inhibrx Biosciences?
Inhibrx Biosciences all-time high quarterly net profit is $1.86 B
What is Inhibrx Biosciences quarterly net income year-on-year change?
Over the past year, INBX quarterly net profit has changed by -$1.90 B (-102.36%)
What is Inhibrx Biosciences TTM net profit?
The current TTM net income of INBX is $1.76 B
What is the all time high TTM net income for Inhibrx Biosciences?
Inhibrx Biosciences all-time high TTM net profit is $1.76 B
What is Inhibrx Biosciences TTM net income year-on-year change?
Over the past year, INBX TTM net profit has changed by +$7.92 M (+0.45%)